Department of General Surgery, The Fourth Affiliated Hospital, China Medical University, Shenyang, 110032, China.
Shenyang Clinical Medical Research Center for Diagnosis, Treatment and Health Management of Early Digestive Cancer, Shenyang, 110032, China.
Cell Death Dis. 2023 Jul 8;14(7):409. doi: 10.1038/s41419-023-05929-3.
Cancer stem cells(CSCs) play a key role in regulating tumorigenesis, progression, as well as recurrence, and possess typical metabolic characteristics. Autophagy is a catabolic process that can aid cells to survive under stressful conditions such as nutrient deficiency and hypoxia. Although the role of autophagy in cancer cells has been extensively studied, CSCs possess unique stemness, and their potential relationship with autophagy has not been fully analyzed. This study summarizes the possible role of autophagy in the renewal, proliferation, differentiation, survival, metastasis, invasion, and treatment resistance of CSCs. It has been found that autophagy can contribute to the maintenance of CSC stemness, facilitate the tumor cells adapt to changes in the microenvironment, and promote tumor survival, whereas in some other cases autophagy acts as an important process involved in the deprivation of CSC stemness thus leading to tumor death. Mitophagy, which has emerged as another popular research area in recent years, has a great scope when explored together with stem cells. In this study, we have aimed to elaborate on the mechanism of action of autophagy in regulating the functions of CSCs to provide deeper insights for future cancer treatment.
癌症干细胞(CSCs)在调节肿瘤发生、进展以及复发方面发挥着关键作用,并且具有典型的代谢特征。自噬是一种分解代谢过程,可以帮助细胞在营养缺乏和缺氧等应激条件下存活。尽管自噬在癌细胞中的作用已经得到了广泛的研究,但 CSCs 具有独特的干性,其与自噬的潜在关系尚未被充分分析。本研究总结了自噬在 CSCs 的更新、增殖、分化、存活、转移、侵袭和治疗耐药性方面的可能作用。已经发现,自噬有助于维持 CSC 的干性,使肿瘤细胞适应微环境的变化,并促进肿瘤的存活,而在其他一些情况下,自噬作为一个重要的过程,参与剥夺 CSC 的干性,从而导致肿瘤的死亡。近年来,作为另一个热门研究领域的线粒体自噬,与干细胞一起探索具有很大的前景。在本研究中,我们旨在阐述自噬在调节 CSCs 功能中的作用机制,为未来的癌症治疗提供更深入的见解。
Cell Death Dis. 2023-7-8
Adv Exp Med Biol. 2023
Cancer Lett. 2017-5-1
Clin Exp Med. 2023-9
Mol Biol Rep. 2022-7
Int J Dev Biol. 2015
Biochem Pharmacol. 2023-6
Expert Rev Mol Med. 2024-10-8
Front Cell Dev Biol. 2020-4-24
Cell Death Dis. 2025-9-1
J Exp Clin Cancer Res. 2025-8-30
Curr Issues Mol Biol. 2025-6-14
Biomedicines. 2025-6-18
Cancer Cell Int. 2024-12-18
Biomed Pharmacother. 2023-4
EMBO J. 2023-3-1
Nat Rev Mol Cell Biol. 2023-3
Cold Spring Harb Perspect Biol. 2023-1-3
Mol Psychiatry. 2023-1